Trial Outcomes & Findings for Yoga and Aerobic Exercise in Psychosis (NCT NCT01207219)

NCT ID: NCT01207219

Last Updated: 2014-12-09

Results Overview

Total number of corrected encoded words in the first three trials in the random condition of Hong Kong List Learning test.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

140 participants

Primary outcome timeframe

baseline and 12 weeks

Results posted on

2014-12-09

Participant Flow

The recruitment period is from Oct 2010 to Jan 2013 in three outpatient clinics in Hong Kong.

In order to obtain sufficient imaging data for final analysis, a total of 140 patients were recruited and randomized, 16 of them withdrew before starting intervention. Amongst 124 participants, 9 were excluded from final analysis because of changed diagnosis during study period. 95 of 115 participants completed 12-week study.

Participant milestones

Participant milestones
Measure
Yoga Therapy
Hatha yoga, three sessions per week for 12 weeks, each session lasted around one hour.
Aerobic Exercise
Included walking and cycling, three times per week for 12 weeks, each session lasted around one hour.
Waitlist Control Group
Patients in waitlist were treated as usual and acted as the control group.
Overall Study
STARTED
45
40
39
Overall Study
Included in ITT Analysis
40
37
38
Overall Study
COMPLETED
34
29
32
Overall Study
NOT COMPLETED
11
11
7

Reasons for withdrawal

Reasons for withdrawal
Measure
Yoga Therapy
Hatha yoga, three sessions per week for 12 weeks, each session lasted around one hour.
Aerobic Exercise
Included walking and cycling, three times per week for 12 weeks, each session lasted around one hour.
Waitlist Control Group
Patients in waitlist were treated as usual and acted as the control group.
Overall Study
changed diagnosis during study period
5
3
1
Overall Study
Lost to Follow-up
6
8
6

Baseline Characteristics

Yoga and Aerobic Exercise in Psychosis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Yoga Therapy
n=40 Participants
Hatha yoga, three sessions per week for 12 weeks, each session lasted around one hour.
Aerobic Exercise
n=37 Participants
Included walking and cycling, three times per week for 12 weeks, each session lasted around one hour.
Waitlist Control Group
n=38 Participants
Patients in waitlist were treated as usual and acted as the control group.
Total
n=115 Participants
Total of all reporting groups
Age, Continuous
24.2 years
STANDARD_DEVIATION 6.9 • n=5 Participants
23.6 years
STANDARD_DEVIATION 5.6 • n=7 Participants
25.3 years
STANDARD_DEVIATION 8.2 • n=5 Participants
24.4 years
STANDARD_DEVIATION 7.0 • n=4 Participants
Sex: Female, Male
Female
40 Participants
n=5 Participants
37 Participants
n=7 Participants
38 Participants
n=5 Participants
115 Participants
n=4 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Years of education
11.9 years
STANDARD_DEVIATION 2.1 • n=5 Participants
12.8 years
STANDARD_DEVIATION 3.2 • n=7 Participants
12.3 years
STANDARD_DEVIATION 2.6 • n=5 Participants
12.3 years
STANDARD_DEVIATION 2.7 • n=4 Participants
Length of illness
2.4 years
STANDARD_DEVIATION 1.9 • n=5 Participants
2.5 years
STANDARD_DEVIATION 2.0 • n=7 Participants
1.8 years
STANDARD_DEVIATION 1.9 • n=5 Participants
1.8 years
STANDARD_DEVIATION 1.9 • n=4 Participants
Smoking
Never smoker
37 participants
n=5 Participants
32 participants
n=7 Participants
37 participants
n=5 Participants
106 participants
n=4 Participants
Smoking
Past smoker
0 participants
n=5 Participants
1 participants
n=7 Participants
0 participants
n=5 Participants
1 participants
n=4 Participants
Smoking
Current smoker
3 participants
n=5 Participants
4 participants
n=7 Participants
1 participants
n=5 Participants
8 participants
n=4 Participants
Substance abuse
No substance abuse
40 participants
n=5 Participants
37 participants
n=7 Participants
38 participants
n=5 Participants
115 participants
n=4 Participants
Substance abuse
Substance abuse
0 participants
n=5 Participants
0 participants
n=7 Participants
0 participants
n=5 Participants
0 participants
n=4 Participants
Diagnosis
Schizophrenia
21 participants
n=5 Participants
19 participants
n=7 Participants
19 participants
n=5 Participants
59 participants
n=4 Participants
Diagnosis
Schizoaffective disorder
4 participants
n=5 Participants
6 participants
n=7 Participants
3 participants
n=5 Participants
13 participants
n=4 Participants
Diagnosis
Schizophreniform disorder
0 participants
n=5 Participants
1 participants
n=7 Participants
0 participants
n=5 Participants
1 participants
n=4 Participants
Diagnosis
Brief psychosis
1 participants
n=5 Participants
1 participants
n=7 Participants
0 participants
n=5 Participants
2 participants
n=4 Participants
Diagnosis
Psychosis not otherwise specified
13 participants
n=5 Participants
8 participants
n=7 Participants
15 participants
n=5 Participants
36 participants
n=4 Participants
Diagnosis
Delusional disorder
1 participants
n=5 Participants
2 participants
n=7 Participants
1 participants
n=5 Participants
4 participants
n=4 Participants
Antipsychotic medication dose, Chlorpromazine (CPZ)
348 mg/day
STANDARD_DEVIATION 268 • n=5 Participants
301 mg/day
STANDARD_DEVIATION 245 • n=7 Participants
260 mg/day
STANDARD_DEVIATION 211 • n=5 Participants
305 mg/day
STANDARD_DEVIATION 244 • n=4 Participants
Positive and Negative Syndrome Scale (PANSS) total score
46.9 units on a scale
STANDARD_DEVIATION 15.8 • n=5 Participants
46.8 units on a scale
STANDARD_DEVIATION 16.4 • n=7 Participants
45.4 units on a scale
STANDARD_DEVIATION 15.2 • n=5 Participants
46.4 units on a scale
STANDARD_DEVIATION 15.7 • n=4 Participants
Calgary Depression Scale (CDS) total score
3.6 units on a scale
STANDARD_DEVIATION 3.4 • n=5 Participants
3.4 units on a scale
STANDARD_DEVIATION 4.1 • n=7 Participants
3.7 units on a scale
STANDARD_DEVIATION 4.7 • n=5 Participants
3.6 units on a scale
STANDARD_DEVIATION 4.1 • n=4 Participants

PRIMARY outcome

Timeframe: baseline and 12 weeks

Total number of corrected encoded words in the first three trials in the random condition of Hong Kong List Learning test.

Outcome measures

Outcome measures
Measure
Yoga Therapy
n=40 Participants
Hatha yoga, three sessions per week for 12 weeks, each session lasted around one hour.
Aerobic Exercise
n=37 Participants
Included walking and cycling, three times per week for 12 weeks, each session lasted around one hour.
Waitlist Control Group
n=38 Participants
Patients in waitlist were treated as usual and acted as the control group.
Verbal Acquisition
Baseline
22.8 correctly encoded words
Standard Deviation 5.8
22.0 correctly encoded words
Standard Deviation 7.8
22.7 correctly encoded words
Standard Deviation 7.7
Verbal Acquisition
12 weeks
29.5 correctly encoded words
Standard Deviation 6.3
28.8 correctly encoded words
Standard Deviation 8.2
24.8 correctly encoded words
Standard Deviation 8.2

PRIMARY outcome

Timeframe: baseline and 12 weeks

The total number of correctly recalled words after short-term (10 minutes) and long-term (30 minutes) delay in the random condition of Hong Kong List Learning test.

Outcome measures

Outcome measures
Measure
Yoga Therapy
n=40 Participants
Hatha yoga, three sessions per week for 12 weeks, each session lasted around one hour.
Aerobic Exercise
n=37 Participants
Included walking and cycling, three times per week for 12 weeks, each session lasted around one hour.
Waitlist Control Group
n=38 Participants
Patients in waitlist were treated as usual and acted as the control group.
Verbal Retention
Baseline
14.9 correctly recorded words
Standard Deviation 5.7
15.1 correctly recorded words
Standard Deviation 5.1
14.5 correctly recorded words
Standard Deviation 7.0
Verbal Retention
12 weeks
19.4 correctly recorded words
Standard Deviation 5.9
21.0 correctly recorded words
Standard Deviation 7.2
16.6 correctly recorded words
Standard Deviation 7.3

PRIMARY outcome

Timeframe: baseline and 12 weeks

measured by Digit Span backwards test. In this test, the subject was asked to recall a series of numbers in reverse order. The correctly recalled series were scored as 1, and the test contains 14 sequences of numbers. The range of working memory score is from 0 to 14, with higher values representing better outcome.

Outcome measures

Outcome measures
Measure
Yoga Therapy
n=40 Participants
Hatha yoga, three sessions per week for 12 weeks, each session lasted around one hour.
Aerobic Exercise
n=37 Participants
Included walking and cycling, three times per week for 12 weeks, each session lasted around one hour.
Waitlist Control Group
n=38 Participants
Patients in waitlist were treated as usual and acted as the control group.
Working Memory
Baseline
6.8 Scores on a scale
Standard Deviation 2.7
6.8 Scores on a scale
Standard Deviation 2.5
7.1 Scores on a scale
Standard Deviation 3.3
Working Memory
12 weeks
8.5 Scores on a scale
Standard Deviation 2.9
9.4 Scores on a scale
Standard Deviation 2.9
7.7 Scores on a scale
Standard Deviation 2.7

PRIMARY outcome

Timeframe: baseline and 12 weeks

measured by Letter Cancellation test Q score. The basic version of the task consists of six 52-character rows in which the target character is randomly interspersed approximately 18 times in each row. Subjects were asked to cancel the letter "C" and "E" as quickly as possible. The time to completion, number of error and omission items were recorded. A "quality of search" index (Q), developed by Geldmacher et al., was applied for the analysis. Q is the ratio of correct number to total number of targets multiplied by the ratio of correct number per second. Higher Q scores represent more efficient performance and better attention and concentration. Q scores could range from 0 (worst possible outcome) to 1 (best possible outcome).

Outcome measures

Outcome measures
Measure
Yoga Therapy
n=40 Participants
Hatha yoga, three sessions per week for 12 weeks, each session lasted around one hour.
Aerobic Exercise
n=37 Participants
Included walking and cycling, three times per week for 12 weeks, each session lasted around one hour.
Waitlist Control Group
n=38 Participants
Patients in waitlist were treated as usual and acted as the control group.
Attention and Concentration
Baseline
0.76 Correct number per second
Standard Deviation 0.14
0.71 Correct number per second
Standard Deviation 0.22
0.74 Correct number per second
Standard Deviation 0.15
Attention and Concentration
12 weeks
0.84 Correct number per second
Standard Deviation 0.18
0.77 Correct number per second
Standard Deviation 0.19
0.73 Correct number per second
Standard Deviation 0.17

SECONDARY outcome

Timeframe: Baseline and 12 weeks

Population: One subject in the waitlist control group has not completed all measures both at the baseline and 12 weeks. Measure of clinical severity has been missing in the data set. So that there are 37 subjects' data of clinical severity has been included for analysis.

PANSS total score is computed by summing the scores of positive, negative and general symptom subscores. The range of PANSS total score is from 30 to 210, range of PANSS positive and negative subscores is from 7 to 49, range of PANSS general symptoms subscore is from 16 to 112, with higher values representing worse outcome. CDS total score is computed by summing the scores of nine items of the scale. The range of CDS total score is from 0 to 27, with higher values representing worse outcome.

Outcome measures

Outcome measures
Measure
Yoga Therapy
n=40 Participants
Hatha yoga, three sessions per week for 12 weeks, each session lasted around one hour.
Aerobic Exercise
n=37 Participants
Included walking and cycling, three times per week for 12 weeks, each session lasted around one hour.
Waitlist Control Group
n=37 Participants
Patients in waitlist were treated as usual and acted as the control group.
Severity of Symptoms
PANSS total score-Baseline
46.9 units on a scale
Standard Deviation 15.8
46.8 units on a scale
Standard Deviation 16.4
45.4 units on a scale
Standard Deviation 15.2
Severity of Symptoms
PANSS total score-12 weeks
37.4 units on a scale
Standard Deviation 9.6
39.5 units on a scale
Standard Deviation 11.1
49.0 units on a scale
Standard Deviation 15.8
Severity of Symptoms
PANSS positive subscore-Baseline
9.9 units on a scale
Standard Deviation 3.5
9.7 units on a scale
Standard Deviation 4.6
9.8 units on a scale
Standard Deviation 3.8
Severity of Symptoms
PANSS positive subscore-12 weeks
8.4 units on a scale
Standard Deviation 2.5
8.3 units on a scale
Standard Deviation 2.5
10.0 units on a scale
Standard Deviation 3.5
Severity of Symptoms
PANSS negative subscore-Baseline
11.0 units on a scale
Standard Deviation 4.3
11.2 units on a scale
Standard Deviation 5.7
11.2 units on a scale
Standard Deviation 4.1
Severity of Symptoms
PANSS negative subscore-12 weeks
8.7 units on a scale
Standard Deviation 2.8
9.7 units on a scale
Standard Deviation 3.8
12.6 units on a scale
Standard Deviation 5.1
Severity of Symptoms
PANSS general symptoms-Baseline
26.0 units on a scale
Standard Deviation 9.5
25.9 units on a scale
Standard Deviation 9.5
24.5 units on a scale
Standard Deviation 9.2
Severity of Symptoms
PANSS general symptoms-12 weeks
20.3 units on a scale
Standard Deviation 5.6
21.6 units on a scale
Standard Deviation 6.9
26.4 units on a scale
Standard Deviation 9.6
Severity of Symptoms
CDS-Baseline
3.6 units on a scale
Standard Deviation 3.4
3.4 units on a scale
Standard Deviation 4.1
3.7 units on a scale
Standard Deviation 4.7
Severity of Symptoms
CDS-12 weeks
1.7 units on a scale
Standard Deviation 2.5
1.7 units on a scale
Standard Deviation 2.4
4.3 units on a scale
Standard Deviation 4.3

Adverse Events

Yoga Therapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Aerobic Exercise

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Waitlist Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr.Lin Jingxia

The Department of Psychiatry,HKU

Phone: +85222553064

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place